Skip to main content
OpenTrials

Clinical trial condition

Hemolysis

Explore clinical trials studying Hemolysis. Study availability and eligibility vary by location and protocol.

81 public trials 14 recruiting studies
Refine in advanced search Browse all conditions

Hemolysis trial results

Completed

Observational Study of Elizaria® in aHUS Patients

NCT04749810

Conditions
Anemia, Anemia, Hemolytic, Atypical Hemolytic Uremic Syndrome, +21 more
Locations
  • Federal State Budgetary Educational Institution of Higher Education "Kazan State Medical University" of the Ministry of Health of the Russian Federation Kazan', Russia
  • Regional State Budgetary Healthcare Institution "Krasnoyarsk' Regional Clinical Center for Maternity and Childhood Protection" Krasnoyarsk, Russia
  • State budgetary healthcare institution of the city of Moscow "Children's City Clinical Hospital of St. Vladimir of the Healthcare Department of the City of Moscow" Moscow, Russia
  • Federal State Autonomous Educational Institution of Higher Education "First Moscow State Medical University n.a. I.M. Sechenov" of the Ministry of Health of the Russian Federation Moscow, Russia
View Trial Details
Completed

Efficacy and Safety of Elizaria® vs. Soliris® in Patients With PNH

NCT04463056

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +20 more
Locations
  • Federal State Budget Funded Institution National Medical Research Center of Hematology, Ministry of Health of the Russian Federation (MoH of Russia) Moscow, Russia
  • Moscow State Budget Funded Healthcare Institution S. P. Botkin City Clinical Hospital, Moscow Department of Healthcare Moscow, Russia
  • State Budget Funded Institution of Higher Education Academician I. P. Pavlov Saint-Petersburg State Medical University of the Ministry of Health of the Russian Federation Saint Petersburg, Russia
  • State Budgetary Educational Institution of Higher Professional Education Samara State Medical University, Ministry of Health of the Russian Federation. Samara, Russia
View Trial Details
Completed

A Phase I Study to Assess the Safety of Pegcetacoplan (APL-2) as an Add-On to Standard of Care in Subjects With PNH

NCT02264639

Conditions
Anemia, Anemia, Hemolytic, Bone Marrow Diseases, +18 more
Locations
  • University of Southern California Norris Comprehensive Cancer Center Los Angeles, California, United States
  • Lakes Research Miami Lakes, Florida, United States
  • University of Lousiville Louisville, Kentucky, United States
  • John Hopkins Hospital Baltimore, Maryland, United States
View Trial Details

Related conditions